Sean Tipton underscores the importance of payer adoption of new treatments and technology which can lead to better patient outcomes.
This is a video synopsis/summary of a Population Health Perspectives® involving Sean Tipton. In the video, Tipton stresses that all parties involved in reproductive care, from device manufacturers to payers and providers, share the goal of healthy patients able to build families. He highlights the importance of payers and providers maintaining open communication, aided by resources like the American Society for Reproductive Medicine (ASRM) that impartially evaluate new techniques’ readiness for widespread use based on aggregated data. Tipton advises that beyond covering infertility treatment, payers must actively work to understand evolving science and technology in partnership with providers and groups like ASRM. He suggests reducing patient demands could boost outcomes, enhance experiences and control costs. For example, fertility medication delivery innovations that decrease patient discomfort and time investments can compel payers to update their formulas. Overall, education and dialogue are central to adapting compensation to advancing practices for optimal efficiency and success. Payers should share information with providers on promising developments to collaboratively determine appropriate payment models centered on patient process streamlining and improved results.
Video synopsis is AIgenerated and reviewed by Managed Healthcare Executive® editorial staff.
Evolving Role of Statins in Managing CV Risk in HIV | ID Week 2024
October 18th 2024Statins have had an evolving role in the management of cardiovascular risk in people living with HIV, explained Michelle Cespedes, M.D., M.S., professor of medicine, Icahn School of Medicine at Mount Sinai and Mount Sinai Health System.
Read More